Skip to content

Cash ratio at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
0.2×-0.8×
ALN
Alnylam PharmaceuticalsALNY
1.3×+0.3×
BridgeBio Pharma logo
BridgeBio PharmaBBIO
1.1×-2.5×
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
0.7×-0.4×
Royalty Pharma logo
Royalty PharmaRPRX
1.1×+0.2×
AbbVie logo
AbbVieABBV
0.2×+0.1×

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$11.52B+402%
Enterprise value$11.44B+418%
P/S18.5×+14.3×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Calculated from Arrowhead Research’s reported figures.

Based on the most recent quarter.

The official record: Arrowhead Research’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arrowhead Research's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arrowhead Research's cash ratio?
Arrowhead Research (ARWR) reported cash ratio of 0.6× in Q1 2026.
How has Arrowhead Research's cash ratio changed year-over-year?
Arrowhead Research's cash ratio decreased by 24.2% year-over-year, from 0.8× to 0.6×.
What is the long-term trend for Arrowhead Research's cash ratio?
Over 5 years (2020 to 2025), Arrowhead Research's cash ratio has grown at a -20.0% compound annual growth rate (CAGR), from 3.5× to 1.2×.
What does cash ratio mean?
How much of its short-term bills the company could pay with cash on hand right now.
How do you interpret cash ratio?
A buffer against stress, but persistently high cash ratios can indicate under-deployed capital. Interpret alongside the company's capital-allocation strategy.
How does cash ratio compare across companies?
Varies widely by business model and treasury policy; best read against the company's own history.